Bionano Genomics (BNGO) Income from Continuing Operations (2017 - 2026)
Bionano Genomics (BNGO) reported Income from Continuing Operations of 8303000.0 for Q1 2026, down 167.67% on a YoY basis from 12270560.27 in Q1 2025, and down 144.84% sequentially from 18517000.0 in Q4 2025.
Bionano Genomics (BNGO) Income from Continuing Operations (2017 - 2026) Analysis & Trends
Bionano Genomics (BNGO) has 10 years of Income from Continuing Operations data on file, last reported at 8303000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 167.67% year-over-year to 8303000.0; the trailing twelve-month figure through Mar 2026 stood at 5146000.0 (up 93.88% YoY), and the FY2025 full-year result was 55000.0, up 100.05% from the prior year.
- Income from Continuing Operations slipped to 8303000.0 in Q1 2026, from 18517000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 18517000.0 in Q4 2025 to a low of 112566000.0 in Q3 2023.
- A 5-year average of 28569882.35 and a median of 31422000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 253.88% in 2023 and jumped 190.51% in 2025, its largest moves.
- Tracing BNGO's Income from Continuing Operations over 5 years: stood at 38677000.0 in 2022, then fell by 13.48% to 43891000.0 in 2023, then jumped by 53.39% to 20459000.0 in 2024, then jumped by 190.51% to 18517000.0 in 2025, then sank by 144.84% to 8303000.0 in 2026.
- Business Quant data shows BNGO's Income from Continuing Operations at 8303000.0 in Q1 2026, 18517000.0 in Q4 2025, and 8503000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Bionano Genomics | 4.34 Mn | -9.35 Mn | 3.25 Mn | -8.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.30 Mn |
| Dec 31, 2025 | 18.52 Mn |
| Sep 30, 2025 | -8.50 Mn |
| Jun 30, 2025 | -6.86 Mn |
| Mar 31, 2025 | -3.10 Mn |
| Dec 31, 2024 | -20.46 Mn |
| Sep 30, 2024 | -44.25 Mn |
| Jun 30, 2024 | -16.22 Mn |
| Mar 31, 2024 | -31.42 Mn |
| Dec 31, 2023 | -43.89 Mn |
| Sep 30, 2023 | -112.57 Mn |
| Jun 30, 2023 | -38.91 Mn |
| Mar 31, 2023 | -37.12 Mn |
| Dec 31, 2022 | -38.68 Mn |
| Sep 30, 2022 | -31.81 Mn |
| Jun 30, 2022 | -32.16 Mn |
| Mar 31, 2022 | -29.95 Mn |
| Dec 31, 2021 | -22.95 Mn |
| Sep 30, 2021 | -20.75 Mn |
| Jun 30, 2021 | -18.79 Mn |